TAC1: Tachykinin Precursor 1

Key regulator of pain, inflammation, and neurotransmission

Gene Information Card

Symbol TAC1
Full Name Tachykinin Precursor 1
Gene Type protein-coding
Chromosomal Location 7q21.3
NCBI Gene ID 6863 ncbi.nlm.nih.gov/gene/6863
Ensembl ID ENSG00000006128
UniProt ID P20366
OMIM ID 162320
HGNC ID 11517
Aliases NKNA, TAC2, PPT, PPT-A, TAC1

Description

The TAC1 gene encodes a preproprotein that is proteolytically processed to generate multiple tachykinin peptides, including substance P and neurokinin A. These peptides act as neurotransmitters and neuromodulators, playing critical roles in pain perception, inflammation, smooth muscle contraction, and neurogenic inflammation. TAC1 expression is predominantly in the nervous system and immune cells.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Depression Altered substance P signaling in the brain; TAC1 polymorphisms associated with mood disorders ClinVar, NCBI
Asthma Tachykinins induce bronchoconstriction and airway inflammation via NK1 and NK2 receptors NCBI, OMIM
Rheumatoid Arthritis Substance P promotes synovial inflammation and pain transmission NCBI, OMIM
Irritable Bowel Syndrome TAC1-derived peptides modulate gut motility and visceral hypersensitivity NCBI
Cancer (various) TAC1 expression linked to tumor growth, angiogenesis, and metastasis in breast, lung, and colon cancers COSMIC, NCBI

Expression Profile

Tissue Expression
Tissue nTPM level
Brain 25.6 High
Spinal cord 18.3 High
Lung 4.2 Medium
Intestine 3.1 Medium
Heart 1.5 Low
Cell Line Expression
Cell Line nTPM Notes
SH-SY5Y (neuroblastoma) 12.4 Neuronal model
A549 (lung carcinoma) 6.8 Epithelial lung cancer
MCF7 (breast cancer) 3.2 Hormone-responsive breast cancer
HEK293 (embryonic kidney) 0.5 Low expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.226C>T (p.Arg76Trp) Missense <0.1% Altered peptide processing; potential impact on pain sensitivity
c.398G>A (p.Arg133Gln) Missense <0.1% Reduced substance P production; associated with depression risk
c.123_124insA Frameshift <0.01% Loss of function; rare
Mutation functional classification

Loss of Function (LOF)

Frameshift and nonsense mutations lead to truncated or absent tachykinin peptides, reducing neurogenic inflammation and pain signaling.

Gain of Function (GOF)

Missense mutations that increase peptide stability or receptor affinity may enhance pain and inflammatory responses.

Dominant Negative (DN)

Not well documented; potential interference with peptide dimerization or processing.

Pathways

Tachykinin signaling via NK1 receptor (hsa04080)
Neuroactive ligand-receptor interaction (hsa04080)
Inflammatory mediator regulation of TRP channels (hsa04750)

Protein Summary

The TAC1 gene product is a 129-amino-acid preproprotein that is cleaved into multiple bioactive peptides: substance P (SP), neurokinin A (NKA), neuropeptide K, and neuropeptide gamma. Substance P is the most studied, acting primarily through the NK1 receptor to mediate pain transmission, vasodilation, and immune cell activation. The protein is expressed in central and peripheral neurons, as well as in immune and endothelial cells.

Related Products

Product name Cat.No. Species Gene ID
TAC1 Knockout HEK293 Cell Line EDJ-KQ1901 Human 6863 Details Get a Quote
CRTAC1 Knockout HEK293 Cell Line EDJ-KQ13006 Human 55118 Details Get a Quote
CRTAC1 Knockout HeLa Cell Line EDJ-KQ42266 Human 55118 Details Get a Quote
TAC1 Knockout HeLa Cell Line EDJ-KQ54604 Human 6863 Details Get a Quote
TAC1 Knockout A-549 Cell Line EDJ-KQ63084 Human 6863 Details Get a Quote
CRTAC1 Knockout A-549 Cell Line EDJ-KQ65036 Human 55118 Details Get a Quote
TAC1 Knockout HCT 116 Cell Line EDJ-KQ71557 Human 6863 Details Get a Quote
CRTAC1 Knockout HCT 116 Cell Line EDJ-KQ73481 Human 55118 Details Get a Quote
Displaying Records 1 To 8 Of 8 Records
Contact Us
*
*
*
*
How did you hear about us: